PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 2 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Ethanol extract of longan leaves (ELL) is being evaluated for anti-colorectal cancer activity using computational prediction and in vitro validation [PMID:41831727].
Longan leaf polysaccharides (LLP) demonstrated therapeutic potential against A. hydrophilia in in vitro experiments [PMID:40436167].
Evidence summary
PubMed sources
- 1.PMID: 41831727 (2026) — From computational prediction to in vitro experimental validation: Identifying active compounds in longan leaves and their anti-colorectal cancer mechanisms. · Fitoterapia
- 2.PMID: 40436167 (2025) — Exploring the pathogenic role of Aeromonas hydrophilia in skin ulcer disease in turtles: Insights into treatment with longan leaf polysaccharides. · International journal of biological macromolecules